Pages that link to "Q36309183"
Jump to navigation
Jump to search
The following pages link to Glucagon-like peptide 1 (GLP-1) and metabolic diseases (Q36309183):
Displaying 13 items.
- Glucose dysregulation and response to common anti-diabetic agents in the FATZO/Pco mouse. (Q33825537) (← links)
- Sustained exendin-4 secretion through gene therapy targeting salivary glands in two different rodent models of obesity/type 2 diabetes (Q34341759) (← links)
- Uncoupling protein 2 regulates glucagon-like peptide-1 secretion in L-cells (Q36093376) (← links)
- Exendin-4 improves resistance to Listeria monocytogenes infection in diabetic db/db mice (Q36306579) (← links)
- Time to insulin in type-2 diabetes: high hurdles or Santiago way? (Q37137599) (← links)
- Exenatide: a review from pharmacology to clinical practice (Q37453614) (← links)
- From Theory to Clinical Practice in the Use of GLP-1 Receptor Agonists and DPP-4 Inhibitors Therapy (Q37900151) (← links)
- Comparative Study to Predict Dipeptidyl Peptidase IV Inhibitory Activity of β-Amino Amide Scaffold (Q41015928) (← links)
- Glucagon-like peptide-1 response to meals and post-prandial hyperglycemia in Type 2 diabetic patients (Q43270578) (← links)
- Glucose-lowering activity of the dipeptidyl peptidase-4 inhibitor saxagliptin in drug-naive patients with type 2 diabetes (Q46691051) (← links)
- Influence of Diet and Gender on Plasma DPP4 Activity and GLP-1 in Patients with Metabolic Syndrome: An Experimental Pilot Study (Q59866796) (← links)
- Appetite hormones and energy intake in obese men after consumption of fructose, glucose and whey protein beverages (Q80532417) (← links)
- A Novel Antidiabetic Food Produced via Solid-State Fermentation of Tartary Buckwheat by L. plantarum TK9 and L. paracasei TK1501 (Q95360157) (← links)